SCHEMBL28619124

SCHEMBL28619124

COC(=O)c1ccc2c(c1)C=NC=CS2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
CA12 O43570 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
XDH P47989 1/20 0.42
PTPRC P08575 1/20 0.41
TRPA1 O75762 4/20 0.41
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 4/20 0.41
HSD17B10 Q99714 3/20 0.41
ALOX15 P16050 3/20 0.41
CASP1 P29466 2/20 0.41
CASP7 P55210 2/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 3/20 0.40
HPGD P15428 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27878308 0.73 CA1 (0.46) CA1CA2CA12CA7CA9
SCHEMBL27580605 0.71 CA1 (0.42) CA1CA2CA12CA7CA9
Hydrochloric Acid SCHEMBL27580591 0.70 CA12 (0.41) CA1CA2CA12CA7CA9
SCHEMBL69897 0.69 CA1 (0.55) CA1CA2CA12CA7CA9
SCHEMBL9508150 0.69 CA1 (0.55) CA1CA2CA12CA7CA9
SCHEMBL9295482 0.67 PTPRC (0.62) CA1CA2CA12CA7CA9
SCHEMBL21170614 0.66 TRPA1 (0.46) CA1CA2CA12CA7CA9
SCHEMBL2880869 0.66 PTPRC (0.49) CA1CA2CA12CA7CA9
SCHEMBL21383082 0.65 ALDH1A1 (0.61) CA1CA2CA12CA7CA9
SCHEMBL9511152 0.65 KDM4E (0.52) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116964048-A Bicyclic tetrahydroazepine derivatives for the treatment of cancer 豪夫迈·罗氏有限公司 2023-10-27 CN disclosed
CN-107889487-B Bicyclic tetrahydrothiazepine derivatives for the treatment of tumor and/or infectious diseases 阿派隆生物制剂股份公司 2021-09-03 CN disclosed